How Phenomic AI uses machine learning and TileDB for scalable single-cell analysis

Phenomic AI is revolutionizing cancer therapies by scaling single-cell data analysis, as highlighted in a recent tech talk webinar featuring Sam Cooper, CTO and Co-Founder. The company, leveraging TileDB's multidimensional array storage solution, overcame the limitations of traditional tabular databases that struggled with their vast dataset of nearly 100 million cells. This transition has facilitated efficient data management and querying, crucial for their advanced machine learning applications in single-cell research, which enhance target discovery for cancer therapies. Additionally, Phenomic AI has tackled the challenges of data alignment and batch effects by developing a machine learning-powered data alignment pipeline, improving interoperability and collaboration across 48 different studies. This innovative approach not only optimizes their models but also ensures seamless research collaboration within their team, supported by TileDB's integrated platform.